Business Description
RVL Pharmaceuticals PLC
NAICS : 325412
SIC : 2833
ISIN : IE00BF2HDL56
Description
RVL Pharmaceuticals PLC is a pharmaceutical company focused on the commercialization and development of products that target markets with underserved patient populations in the ocular medicine and medical aesthetics therapeutic areas. Its revenues consist of product sales, royalty revenues and licensing revenue.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
FCF Margin % | -128.62 | |||||
OCF Margin % | -120.29 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
EV-to-Forward-EBITDA | 5.06 | |||||
EV-to-Forward-Revenue | 1.02 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:RVLPQ
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
RVL Pharmaceuticals PLC Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 36.919 | ||
| EPS (TTM) ($) | -0.7 | ||
| Beta | -11.1162 | ||
| 3-Year Sharpe Ratio | -0.32 | ||
| 3-Year Sortino Ratio | -0.68 | ||
| Volatility % | - | ||
| 14-Day RSI | - | ||
| 14-Day ATR ($) | - | ||
| 20-Day SMA ($) | 0.00001 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 0.00001 - 0.00001 | ||
| Shares Outstanding (Mil) | 111.41 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
RVL Pharmaceuticals PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
RVL Pharmaceuticals PLC Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-26 | In 151 days | ||
| Third quarter earnings results for 2026 | 2026-11-26 | In 151 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-03 | In 36 days | ||
| Second quarter earnings results for 2026 | 2026-08-03 | In 36 days | ||
| General meeting for 2025 | 2026-07-01 | In 3 days | ||
| Annual report for 2025 | 2026-06-30 | In 2 days | ||
| First quarter earnings conference call for 2026 | 2026-06-26 | 0.00 (+0.00%) | ||
| First quarter earnings results for 2026 | 2026-06-26 | 0.00 (+0.00%) | ||
| First quarter earnings conference call for 2026 | 2026-05-15 | 0.00 (+0.00%) | ||
| First quarter earnings results for 2026 | 2026-05-15 | 0.00 (+0.00%) |
Show
Entries
RVL Pharmaceuticals PLC Frequently Asked Questions
What is RVL Pharmaceuticals PLC(RVLPQ)'s stock price today?
The current price of RVLPQ is $0.00. The 52 week high of RVLPQ is $0.00 and 52 week low is $0.00.
When is next earnings date of RVL Pharmaceuticals PLC(RVLPQ)?
The next earnings date of RVL Pharmaceuticals PLC(RVLPQ) is 2026-08-03 Est..
Does RVL Pharmaceuticals PLC(RVLPQ) pay dividends? If so, how much?
RVL Pharmaceuticals PLC(RVLPQ) does not pay dividend.
Guru Commentaries on OTCPK:RVLPQ
No articles.
Press Release
Articles on RVL Pharmaceuticals PLC
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers